Canada
MNA Rizqy and Minister Fitzgibbon honor the employees of bioMérieux Canada Inc. with the National Assembly Medal for their exceptional contribution during the COVID-19 pandemic
27 June, 2022The bioMérieux Canada team remained true to its commitment towards public health by ensuring the installation of the BIOFIRE® systems in record time. The team traveled across Canada despite the sanitary restrictions to ensure adequate user training and was able to demonstrate agility and innovation...
bioMérieux and Labor Berlin (Charité Vivantes GmbH) to Establish Center of Excellence in Laboratory Diagnostics
05 May, 2011
Labor Berlin and bioMérieux announce the signature of an agreement to create a Center of Excellence for microbiology and enhanced laboratory automation. The center will be located at Europe’s largest hospital laboratory, serving more than 8,000 in-house patients in Berlin and handling over 23 million patient analyses a year.
Ipsen and bioMérieux enter into a broad partnership in personalized medicine
25 February, 2011
The two companies leverage combined expertise in therapeutics and in diagnostics to improve patient care
bioTheranostics’ Breast Cancer IndexSM predicts risk for late recurrence in early stage ER-positive breast cancer patients
10 December, 2010
bioTheranostics, a bioMérieux company that develops innovative oncology diagnostic tests to support targeted disease management, announced today new findings from a clinical study evaluating the company’s Breast Cancer Index (BCI) molecular oncology test. Data from the study were presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).
bioMérieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics
04 November, 2010
Co-development of assays and co-distribution of a fully integrated molecular platform due for launch in 2012. bioMérieux gains exclusive rights in microbiology. bioMérieux takes equity stake in Biocartis.
bioMérieux Introduces Revolutionary LockSure® Plate Technology
07 September, 2010